+1 862 207 3288 write a report to an investment firm on the market for normal-tension glaucoma to decide whether or not to invest in Renetx (http://www.renetx.com/technology.html), a biotech firm that is researching neuroprotective therapy for glaucoma. Currently, all treatments are aimed towards lowering eye pressure in glaucoma, however there are many patients who have glaucoma and have standard eye pressure. do market research on the number of cases of normal-tension glaucoma, in the United States and in Asia (China). I also have to assess competitors in the field that are also doing research and their progress. So basically, how many cases of glaucoma are there in the US and Asia(china), and is there anybody else with a treatment for normal-tension glaucoma? Is it an umet need, partially unmet and who’s addressing it?
